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Nuclear factor kappa B (NF-κ B) is a
pleiotropic transcriptional factor involved in
the inducible expression of a wide variety of
genes, particularly those that promote cell
growth and survival and that protect cells from
apoptotic death stimuli (1). NF-κ B is a het-
erodimer most frequently comprising a 50-
kDa protein called p50 or NF-κ B1 and a
65-kDa protein referred to as p65 or relA. In
most mammalian cells the NF-κ B heterodimer
resides in the cytoplasm in the inactive form,
bound to an inhibitor protein, Iκ B. Upon
exposure of the cell to a variety of stimuli such
as growth factors, bacterial lipopolysaccharide
(LPS, endotoxin), or cytokines such as tumor
necrosis factor-α (TNF-α ), inhibitory kappa B
(Iκ B) is phosphorylated and ubiquinated,
allowing it to be degraded by the 26S proteo-
some. This results in release of the active NF-
κ B heterodimer, which then translocates to the
nucleus and mediates the upregulation of spe-
ciﬁc pro-survival and anti-apoptotic genes by
binding to the κ B consensus sequence in their
regulatory regions.
Many of the steps in the signaling path-
way leading to NF-κ B activation are known
to possess conserved cysteine moieties and to
require reduced thiol groups for optimal sig-
nal transduction and DNA binding (2). In
previous studies (3,4), we have demonstrated
that NF-κ B is readily activated by LPS and
TNF-α in normal rat kidney epithelial cells.
Moreover, we have shown that mercuric ion
(Hg2+), one of the most potent thiol-directed
agents known, attenuates NF-κ B activation
in kidney cells at concentrations as low as
2µ M (i.e., ~2 nmol/mg protein). These
effects of Hg2+ are directed toward impair-
ment of Iκ B phosphorylation, translocation
of p65 to the nucleus, and NF-κ B–DNA
binding. These actions result in attenuated
NF-κ B transcriptional activity, as determined
in kidney cells transiently transfected with an
NF-κ B–driven luciferase reporter plasmid
(pLuc-4 ×  NF-κ B) (4,5).
In the studies described here, we investi-
gated the implications of Hg2+-mediated
attenuation of NF-κ B activity in kidney cells
with respect to Hg2+-induced nephrotoxicity.
Underlying this investigation are two basic
tenets. The first is that apoptosis plays an
important role in the pathogenesis of those
forms of renal failure in which tubular epithe-
lial cells are the primary target of toxicant
injury (6), as occurs with Hg2+ exposure (7).
The second is that NF-κ B prevents apoptosis
in numerous cell types by promoting the
upregulation of specific anti-apoptotic gene
products, such as Bcl-2 and the zinc finger
protein A20 (8,9). Because Hg2+ impairs
NF-κ B activation at cellular concentrations
that do not prevent cellular energy produc-
tion (i.e., <20 µM), we hypothesized that
Hg2+ promotes cell death by increasing the
sensitivity of kidney cells to the apoptosis-
inducing effects of agents such as TNF-α and
LPS, to which kidney cells are normally resis-
tant because of their ability to otherwise
activate NF-κ B.
Materials and Methods
Materials 
Lipopolysaccharide from Escherichia coli
(serotype 026:B6) and HgCl2 (Sigma
M1136) were acquired from the Sigma
Chemical Co. (St. Louis, MO, USA). TNF-α
(human recombinant, E. coli, catalog no.
654205; 1 ng = 110 WHO IU) was obtained
from Calbiochem (La Jolla, CA, USA). All
other chemicals were purchased from stan-
dard commercial sources and were of the
highest available purity.
Cell Culture and Treatments 
NRK52E cells, a clonal line established
from normal rat tubular epithelial cells
(ATCC no. CRL-1571), were acquired from
the American Type Culture Collection
(Manassas, VA, USA) and were propagated in
Dulbecco’s modiﬁed Eagle’s medium with high
glucose, pyruvate, and L-glutamate (Cambrex;
Biowhittaker, North Brunswick, NJ, USA)
supplemented with 5% heat-inactivated
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Nuclear factor kappa B (NF-κ B), a pleiotropic transcriptional factor that promotes cell survival
and protects cells from apoptosis, requires reduced thiols at critical steps in its activation pathway.
Mercuric ion (Hg2+), one of the strongest thiol-binding agents known, impairs NF-κ B activation
and transcriptional activity in normal rat kidney epithelial (NRK52E) cells at concentrations as
low as 0.5 µM by binding to speciﬁc reduced thiol moieties in the NF-κ B activation pathway. We
hypothesized that prevention of NF-κ B activation by Hg2+ will increase the sensitivity of kidney
cells to the apoptosis-inducing effects of other toxicants to which these cells are otherwise resistant
by virtue of their NF-κ B–activating capacity. Fewer than 5% of untreated kidney cells in culture
(70–90% conﬂuent) were found to be apoptotic when evaluated by DNA fragmentation (terminal
deoxynucleotide transferase-mediated dUTP nick-end labeling) or flow cytometric DNA profile
analyses. Hg2+ (5 µM) treatment for 24 hr increased this proportion by 1.5- to 2-fold. Neither
lipopolysaccharide (LPS) (1 µg/mL) nor tumor necrosis factor-α (TNF-α ; 300 U/mL), both
potent activators of NF-κ B in kidney cells, signiﬁcantly altered the proportion of apoptotic cells,
compared with untreated controls, when applied without Hg2+ pretreatment. However, when LPS
or TNF-α was administered after Hg2+ pretreatment (5 µM for 30 min), the proportion of cells
undergoing apoptosis 22 hr later increased by 4- to 6-fold compared with untreated controls. In
contrast, Hg2+ pretreatment did not increase the amount of apoptosis caused by apoptosis-induc-
ing agents that do not activate NF-κ B (staurosporine, Fas ligand). These findings suggest that
Hg2+ enhances the sensitivity of kidney cells to apoptotic stimuli as a consequence of inhibition of
NF-κ B activity. Because apoptosis is known to play a key role in the pathogenesis of renal failure
resulting from toxicant injury to proximal tubular cells, promotion of apoptosis via inhibition of
NF-κ B activity may define a novel molecular mechanism by which Hg2+ toxicity is initiated in
kidney cells. Key words: apoptosis, kidney, mercuric ion, mercury, nephrotoxicity, nuclear factor-
κ B. Environ Health Perspect 110(suppl 5):819–822 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-5/819-822woods/abstract.html
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newborn calf serum (GIBCO; Invitrogen,
Carlsbad, CA, USA) plus 100 U/mL peni-
cillin and 100 µg/mL streptomycin (Sigma).
Cell monolayer mats were grown to conflu-
ence in 6- and 12-well plates (Costar,
Corning, NY, USA) and also in 25- and 75-
cm2 cant-necked, vent-capped, uncoated
flasks (Costar). Medium was replaced every
2–5 days, irrespective of state of conﬂuency.
Treatments were performed when cells
covered 70–90% of ﬂask surface.
Electrophoretic Mobility Shift Assays
and Autoradiography 
Electrophoretic mobility shift assays (EMSAs)
to demonstrate activation of NF-κ B in
nuclear protein extracts were performed as
previously described (3,4).
Apoptosis Assays 
Apoptosis of NRK52E cells was detected by
the terminal deoxynucleotide transferase-
mediated dUTP nick-end labeling (TUNEL)
method, using a ﬂuorescein-based TUNEL cell
death detection kit (Boehringer Mannheim,
Indianapolis, IN, USA). The percentage of
apoptotic cells was calculated using a RT
slider spot camera (Diagnostic Instruments
Inc., Sterling Heights, MI, USA) and NIH
Image software (Universal Imaging Corp.,
Downingtown, PA, USA). Additional apop-
tosis assessments were performed by flow
cytometric analysis of cellular DNA content
after ﬁxed cell preparations were stained with
4,6-diamidino-2-phenylindole (DAPI) (10).
Analyses were performed on an ELITE
cytometer (Coulter Corp., Miami, FL, USA)
using ultraviolet laser excitation. Acceptable
histograms were derived from a minimum of
10,000 cells and contained a coefficient of
variation below 6%. DNA content his-
tograms and cell cycles were analyzed using
the MultiCycle software program (Phoenix
Flow Systems, San Diego, CA, USA). The
percentage of apoptotic cells was quantiﬁed as
the percentage of total cells displaying
reduced DNA staining, the sub-G0/G1 peak.
Before analysis, cellular debris was gated out
on the basis of cell scatter.
Statistical Analyses 
Analysis of differences between treatment
groups for EMSA assays was determined
using a paired, one-tailed t-test. The level of
signiﬁcance was chosen at <0.05.
Results
Hg2+ Attenuates NF-κ B Activation 
in Kidney Epithelial Cells 
In previous studies (3) we have demonstrated
activation of NF-κ B by various agents (e.g.,
LPS, TNF-α , thapsigargin) in kidney epithe-
lial cells and have shown that this effect is
defined by specific activation of the p50p65
heterodimer. More recently we have demon-
strated that activation of NF-κ B by such
agents is readily attenuated in a dose-related
manner after pretreatment of cells with low
Hg2+ concentrations (4). Thus, as shown
in Figures 1 and 2, LPS-induced and
TNF-α –induced activation of NF-κ B was
significantly impaired after pretreatment of
cells with Hg2+ at concentrations as low as
0.5 µM. In additional studies, we have
observed similar effects of Hg2+ on NF-κ B
activation by LPS or TNF-α in adult human
renal tubular epithelial cells (Clonetics
RPTEC 5899, Cambrex), as well as by TNF-
α in primary rat astrocytes (data not shown).
These ﬁndings attest to the non–cell-speciﬁc
and non–species-speciﬁc nature of this effect.
Hg2+ Induces Apoptosis in Kidney
Epithelial Cells 
Within the concentration range over which
Hg2+ attenuates NF-κ B activity (<20 µM),
Hg2+ elicits a small but discernable increase in
apoptosis in kidney cells. As shown in Figure
3, the proportion of cells undergoing apopto-
sis increased from fewer than 5% in untreated
cultures (Figure 3A) to 8–10% when evalu-
ated by the TUNEL assay 22 hr after 5 µM
Hg2+ treatment (Figure 3B). Evidence of
Hg2+-induced apoptosis was also obtained
when evaluated using flow cytometric tech-
niques in which the proportion of cells that
fell within the sub-G0/G1 fraction of the total
cell population was identified as apoptotic.
Representative plots of diploid cell cycle
analysis in which DNA content from
untreated (Figure 3C) and Hg2+-treated
(Figure 3D) cell cultures was measured after
DAPI staining are also shown in Figure 3.
We observed similar apoptotic effects after
treatment with Hg2+ at 10 µM; however, no
increased apoptosis was found after treatment
with Hg2+ at 2 µM (not shown).
Hg2+ Pretreatment Enhances the
Sensitivity of Kidney Cells to
Apoptotic Stimuli That Also 
Activate NF-κ B 
Although a small increase in the proportion
of apoptotic cells was found after treatment
with Hg2+ alone, pretreatment of kidney cells
with Hg2+ at concentrations that impair
NF-κ B activation significantly increased the
sensitivity of cells to the apoptosis-inducing
effects of other agents to which these cells are
otherwise resistant because of their capacity to
activate NF-κ B. Thus, as shown in Figure
4A, TNF-α (300 U/mL) elicited no increase
in the proportion of apoptotic cells compared
with untreated controls, when evaluated by
the TUNEL assay 22 hr after treatment. 
In contrast, when TNF-α was administered
to cells 30–45 min after treatment with Hg2+
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Figure 1. Effects of Hg2+ on LPS activation of NF-κ B
in NRK52E cells. (A) EMSA showing dose–response
effects of Hg2+ on p50p65–DNA binding when given
to cells 30 min before LPS (1 µg/mL) administration.
NT, not treated. (B) Binding signals are presented
as a percentage of that for LPS alone. Error bars
show standard deviation. *p < 0.05.
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Figure 2. Effects of Hg2+ on TNF-α activation of
NF-κ B in NRK52E cells. (A) EMSA showing
dose–response effects of Hg2+ on p50p65–DNA
binding when given to cells 30 min before TNF-α
(300 U/mL) administration. (B) Binding signals are
presented as a percentage of that for TNF-α alone.
Error bars show standard deviation.*p < 0.05.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 821
(5 µM) (Figure 4B), a dramatic increase
(>6-fold) in apoptosis was observed. Similar
findings were obtained when apoptosis was
evaluated using ﬂow cytometry, as described
for Figure 3. The proportion of apoptotic cells
increased from fewer than 4% after treatment
with TNF-α alone (same proportion as seen
in untreated cells) to 25% when TNF-α was
given after Hg2+ administration (Figure 4C,
D). Notably, Hg2+ pretreatment increased the
sensitivity of cells to the apoptotic effects of
TNF-α even when administered at concentra-
tions (i.e., <5 µM) that were not sufﬁcient to
elicit a significant increase in apoptosis by
Hg2+ alone (not shown), supporting the view
that the effects of Hg2+ and TNF-α in this
effect are interactive rather than independent
mechanistic events.
The augmentation of sensitivity to the
apoptosis-inducing effect of NF-κ B–activat-
ing agents by Hg2+ was not restricted to
TNF-α . We obtained similar findings when
we substituted LPS for TNF-α in comparable
experiments (Table 1). Notably, apoptosis has
been implicated as an important mechanism
of cell death in vivo after LPS exposure (11).
As shown in Table 1, treatment with LPS
(1 µg/mL) alone increased the proportion of
apoptotic cells to approximately 8% when
measured 22 hr after administration. When
LPS was applied 30 min after Hg2+ pretreat-
ment (5 µM), the amount of apoptosis
increased to more than 35% of total cells.
In contrast Hg2+ pretreatment did not sub-
stantially increase the amount of apoptosis
found after treatment of cells with apoptosis-
inducing agents that do not concomitantly
activate NF-κ B. Staurosporine (200 nM),
which initiates apoptosis by inducing the mito-
chondrial permeability transition (12) without
activating NF-κ B, elicited a signiﬁcant increase
in the proportion of apoptotic cells (27.9%),
and pretreatment with 5 µM Hg2+ did not sig-
nificantly increase the effect of subsequently
administered staurosporine (Table 1). We
obtained similar ﬁndings with anti-Fas ligand
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Figure 3. Apoptosis in NRK52E cells after Hg2+ treatment. Cells were untreated or treated with 5 µM Hg2+
22 hr before harvesting. Apoptosis was evaluated using the TUNEL assay (A and B) or by ﬂow cytometry
(C and D), as described in “Materials and Methods.” Arrows in A and B represent TUNEL-positive cells.
Arrows in C and D represent the sub-G0/G1 cell fraction.
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Figure 4. Enhancement of TNF-α –induced apoptosis in NRK52E cells by Hg2+. Cells were treated with 5 µM
Hg2+ 30 min before TNF-α (300 U/mL) or with TNF-α alone. Cells were harvested 22 hr after TNF-α adminis-
tration. Apoptosis was evaluated using the TUNEL assay (A and B) or by flow cytometry (C and D), as
described in Materials and Methods. Arrows in A and B represent TUNEL-positive cells. Arrows in C and D
represent the sub-G0/G1 cell fraction.
Table 1. Hg2+ augments apoptosis of kidney cells
by agents that activate NF-κ B.a
% Apoptotic cells
No Hg2+ Hg2+
Agent pretreatment pretreatment
None (control) 3.8 7.3*
TNF-α 3.9 24.8*
LPS 8.2 35.1*
Staurosporine 27.9 29.3
Anti-Fas ligand 67.8 68.5 
aApoptosis was determined in NRK52E cells by the TUNEL
assay as described in “Materials and Methods.” Hg2+ (5
µM) pretreatment was performed 30 min before adminis-
tration of the indicated agent. TNF-α (300 U/mL), LPS
(1 µg/mL), staurosporine (200 nM), or anti-Fas ligand
(1 µg/mL) was administered 22–24 hr before apoptosis
determinations. *Significantly greater (p < 0.05) than no
Hg2+ pretreatment (p < 0.05).(1 µg/mL), which induces apoptosis by direct
caspase activation after receptor engagement
(13), without NF-κ B activation.
Discussion
Hg2+ is a potent nephrotoxicant, with pre-
dominant effects directed toward proximal
tubular epithelial cells of the S3 segment (pars
recta) (7,14). Previous studies from this labo-
ratory and others (15–18) have focused largely
on disruption of cellular membranes and
impairment of mitochondrial bioenergetics as
principal events underlying Hg2+ toxicity. In
contrast, few studies have sought to deﬁne the
speciﬁc molecular mechanisms through which
Hg2+ initiates toxicity via alteration of thiol-
dependent signal transduction pathways that
regulate cellular proliferation and survival.
The present findings indicate that Hg2+, at
cellular concentrations that do not compro-
mise cellular energy production, impairs acti-
vation of NF-κ B and that this effect may
increase the sensitivity of kidney cells to the
apoptosis-inducing effects of other toxicants
and infectious agents to which kidney cells are
otherwise resistant. Because apoptosis is
thought to play an important role in the
pathogenesis of renal failure associated with
toxicant injury to tubular epithelial cells (6,9),
the present ﬁndings suggest a novel molecular
mechanism by which Hg2+ may initiate
nephrotoxicity. Moreover, because NF-κ B
plays a key role in preventing apoptosis in
numerous cell types, ﬁndings obtained in the
present kidney cell model might be pertinent
to the etiology of mercury toxicity in the cen-
tral nervous system or other tissues in which
mercury is preferentially accumulated.
Of considerable relevance to the present
observations is the current increased concern
regarding risks and susceptibility to toxicity
that may result from population exposures to
biological agents. The ﬁndings that low-level
mercury exposure may increase the sensitivity
of kidney cells to LPS-mediated toxicity raises
the possibility that such exposure may enhance
susceptibility to E. coli or other biological
agents in other organ systems as well. Notably,
low-level mercury exposure has been reported
to signiﬁcantly enhance susceptibility to infec-
tion from encephalomyocarditis virus (19) and
leishmaniasis (20) in mice and from pseudora-
bies virus in rabbits (21). These observations
suggest that low-level mercury exposure may
promote the toxic effects of biological agents at
tissue concentrations that do not elicit overt
Hg2+ toxicity per se. Confirmation of this
hypothesis through further research would be
of substantial public health significance
because it would suggest potential health risks
associated with considerably lower levels of
Hg2+ exposure than are currently thought to
be of public health concern.
In conclusion, the present studies provide
evidence of a novel molecular mechanism
through which Hg2+, by preventing NF-κ B
activation, promotes toxicity by increasing the
sensitivity of kidney and possibly other tissue
cells to the apoptosis-inducing effects of other
agents. Further studies directed toward conﬁr-
mation of this observation could provide a
mechanistic basis for improved understanding
of a wide range of human health disorders
that are associated with mercury exposure.
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